abstract |
The present invention is directed to absorbable polyether esters that have been found to reduce bacterial adhesion to materials such as medical devices and implants; more specifically, the invention is directed to novel amorphous copolymers comprising polyethylene diglycolate (PEDG) copolymerized with lactide-rich monomers. |